ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
OmniAb Inc

OmniAb Inc (OABI)

4.53
0.03
(0.67%)
At close: May 15 4:00PM
4.53
0.03
( 0.67% )
After Hours: 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.53
Bid
4.41
Ask
4.59
Volume
424,197
4.5167 Day's Range 4.61
3.50 52 Week Range 6.715
Market Cap
Previous Close
4.50
Open
4.56
Last Trade
121472
@
4.54
Last Trade Time
16:00:00
Financial Volume
$ 1,928,813
VWAP
4.547
Average Volume (3m)
539,320
Shares Outstanding
116,238,186
Dividend Yield
-
PE Ratio
-10.45
Earnings Per Share (EPS)
-0.44
Revenue
34.16M
Net Profit
-50.62M

About OmniAb Inc

OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.

Sector
Coml Physical, Biologcl Resh
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2022
OmniAb Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker OABI. The last closing price for OmniAb was $4.50. Over the last year, OmniAb shares have traded in a share price range of $ 3.50 to $ 6.715.

OmniAb currently has 116,238,186 shares outstanding. The market capitalization of OmniAb is $528.88 million. OmniAb has a price to earnings ratio (PE ratio) of -10.45.

OABI Latest News

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep® enable new bispecific antibody discovery workflows for OmniAb’s partners OmniAb, Inc. (Nasdaq: OABI) today announced its...

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2024, and provided operating...

OmniAb to Participate in Five Investor Conferences in May

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global Healthcare Conference, May 14-15...

OmniAb to Report First Quarter 2024 Financial Results on May 9

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May 9, 2024 and will hold a...

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2023, and provided...

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on Wednesday, March 20, 2024 and will...

OmniAb to Participate in Two Investor Conferences in March

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in March. TD Cowen 44th Annual Healthcare Conference, March 4-6, 2024, at...

OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference

Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the...

OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event

Webcast and event slides available here OmniAb, Inc. (Nasdaq: OABI) held its first Research & Technology virtual event earlier today, during which members of the management team reviewed the...

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Webcast including Research & Technology Event begins at 11:00 a.m. Eastern time today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-1.307189542484.594.764.2657450364.57120763CS
4-0.3-6.211180124224.834.864.2655888374.58992579CS
12-1.07-19.10714285715.66.54884.2655393205.1338018CS
26-0.1-2.159827213824.636.7154.215169815.34714011CS
521.0128.69318181823.526.7153.55245325.12856262CS
156-0.54-10.6508875745.076.7151.917348414.11521562CS
260-0.54-10.6508875745.076.7151.917348414.11521562CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0